ALAIN PHILIPPE VASSEROT
Pilots at Ln Paloma St, Carlsbad, CA
License number
California A2781697
Issued Date
Dec 2015
Expiration Date
Dec 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
6421 La Paloma St, Carlsbad, CA 92009
Professional information
Innovative Discovery Of Therapeutic, Diagnostic, And Antibody Compositions Related To Protein Fragments Of Phenylalanyl-Alpha-Trna Synthetases
US Patent:
2013019, Aug 1, 2013
Filed:
May 3, 2011
Appl. No.:
13/696046
Inventors:
Leslie Ann Greene - San Diego CA, US
Kyle P. Chiang - Cardiff CA, US
Fei Hong - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry D. Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
Wing-Sze Lo - Chai Wan, HK
John D. Mendlein - Encinitas CA, US
Kyle P. Chiang - Cardiff CA, US
Fei Hong - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry D. Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
Wing-Sze Lo - Chai Wan, HK
John D. Mendlein - Encinitas CA, US
Assignee:
PANGU BIOPHARMA LIMITED - Hong Kong
a Tyr Pharma, Inc. - San Diego CA
a Tyr Pharma, Inc. - San Diego CA
International Classification:
C12N 9/00, C12N 5/071, G01N 33/68, C12N 9/96, C07K 16/40
US Classification:
424 945, 5303879, 514 193, 514 69, 514 182, 514 213, 514 212, 435183, 435188, 530350, 530324, 435325, 435 74, 435375
Abstract:
Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.
Innovative Discovery Of Therapeutic, Diagnostic, And Antibody Compositions Related To Protein Fragments Of P38 Multi-Trna Synthetase Complex
US Patent:
2013023, Sep 5, 2013
Filed:
May 4, 2011
Appl. No.:
13/696049
Inventors:
Leslie Ann Greene - San Diego CA, US
Kyle P. Chiang - Cardiff CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry Dean Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
John D. Mendlein - Encinitas CA, US
Kyle P. Chiang - Cardiff CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry Dean Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
John D. Mendlein - Encinitas CA, US
Assignee:
ATYR PHARMA, INC. - San Diego CA
International Classification:
C12N 9/00, C12N 5/071, G01N 33/68, C07K 16/40, C12N 9/96
US Classification:
424 945, 5303879, 514 193, 514 182, 514 69, 435183, 435188, 514 212, 530350, 435325, 435 74, 435375
Abstract:
Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.
Humanized Anti-Ghrelin Antibodies
US Patent:
7479271, Jan 20, 2009
Filed:
Feb 9, 2006
Appl. No.:
11/815379
Inventors:
David Matthew Marquis - Encinitas CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Derrick Ryan Witcher - Fishers IN, US
Alain Philippe Vasserot - Carlsbad CA, US
Derrick Ryan Witcher - Fishers IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07K 16/00, C12P 21/08, A61K 39/395, A61K 39/00
US Classification:
4241301, 5303871, 5303879, 53038824, 4241331, 4241451
Abstract:
Humanized antibodies, or antigen-binding portions thereof, that preferentially bind acylated ghrelin with respect to unacylated ghrelin, are disclosed. These molecules have high affinity and a slow off rate for acylated ghrelin, and neutralize acylated ghrelin activity. These antibodies, or antigen-binding portions thereof, are useful for neutralizing acylated ghrelin activity, e. g. , in a subject suffering from a disorder in which ghrelin activity is detrimental, such as obesity.
Thrombopoietic Activity Of Tyrosyl-Trna Synthetase Polypeptides
US Patent:
2010009, Apr 15, 2010
Filed:
Jun 10, 2009
Appl. No.:
12/482151
Inventors:
Rajesh Belani - San Diego CA, US
Jeffry Dean Watkins - Encinitas CA, US
Wei Zhang - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry Dean Watkins - Encinitas CA, US
Wei Zhang - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Assignee:
ATYR PHARMA, INC. - San Diego CA
International Classification:
A61K 35/12, A61K 38/45, A61P 7/00, G01N 33/573, C12N 15/63, C12N 5/00, C12N 5/02, A61P 29/00
US Classification:
424 937, 424 945, 435 74, 4353201, 435325, 435375
Abstract:
Thrombopoietic compositions are provided comprising tyrosyl tRNA synthetase polypeptides, including truncations and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from increased thrombopoiesis, such as thrombocytopenia.
Anti-Il-6 Antibodies, Compositions, Methods And Uses
US Patent:
8226611, Jul 24, 2012
Filed:
Oct 27, 2011
Appl. No.:
13/283177
Inventors:
Yan Chen - Wayne PA, US
Debra Gardner - Bear DE, US
David M. Knight - Berwyn PA, US
Michael W. Lark - Devon PA, US
Bailin Liang - Gilbertsville PA, US
David J. Shealy - Downingtown PA, US
Xiao-Yu R. Song - West Chester PA, US
Raymond W. Sweet - Bryn Mawr PA, US
Susan H. Tam - Boothwyn PA, US
Sheng-Jiun Wu - Broomall PA, US
Jing Yang - Ambler PA, US
David Matthew Marquis - Encinitas CA, US
Eric Michael Smith - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Debra Gardner - Bear DE, US
David M. Knight - Berwyn PA, US
Michael W. Lark - Devon PA, US
Bailin Liang - Gilbertsville PA, US
David J. Shealy - Downingtown PA, US
Xiao-Yu R. Song - West Chester PA, US
Raymond W. Sweet - Bryn Mawr PA, US
Susan H. Tam - Boothwyn PA, US
Sheng-Jiun Wu - Broomall PA, US
Jing Yang - Ambler PA, US
David Matthew Marquis - Encinitas CA, US
Eric Michael Smith - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Assignee:
Janssen Biotech, Inc. - Horsham PA
Applied Molecular Evolution - San Diego CA
Applied Molecular Evolution - San Diego CA
International Classification:
A61M 37/00, A61M 5/32, A61K 39/395, C07K 16/24
US Classification:
604143, 604198, 4241391, 53038823
Abstract:
An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Anti-Il-6 Antibodies, Compositions, Methods And Uses
US Patent:
RE43672, Sep 18, 2012
Filed:
Jul 8, 2011
Appl. No.:
13/178998
Inventors:
Yan Chan - Radnor PA, US
Debra Gardner - Radnor PA, US
David M. Knight - Berwyn PA, US
Michael W. Lark - Berwyn PA, US
Bailin Liang - Jacksonville FL, US
David J. Shealy - Radnor PA, US
Xiao-yu R. Song - Somerville NJ, US
Raymond W. Sweet - Radnor PA, US
Susan H. Tam - Radnor PA, US
Sheng-Jiun Wu - Radnor PA, US
Jing Yang - Ambler PA, US
David Matthew Marquis - Encinitas CA, US
Eric Michael Smith - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Debra Gardner - Radnor PA, US
David M. Knight - Berwyn PA, US
Michael W. Lark - Berwyn PA, US
Bailin Liang - Jacksonville FL, US
David J. Shealy - Radnor PA, US
Xiao-yu R. Song - Somerville NJ, US
Raymond W. Sweet - Radnor PA, US
Susan H. Tam - Radnor PA, US
Sheng-Jiun Wu - Radnor PA, US
Jing Yang - Ambler PA, US
David Matthew Marquis - Encinitas CA, US
Eric Michael Smith - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Assignee:
Janssen Biotech, Inc. - Horsham PA
Applied Molecular Evolution - San Diego CA
Applied Molecular Evolution - San Diego CA
International Classification:
A61K 39/395, C07K 16/24, C12N 5/12
US Classification:
4241391, 53038823, 435326
Abstract:
An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Innovative Discovery Of Therapeutic, Diagnostic, And Antibody Compositions Related To Protein Fragments Of Valyl-Trna Synthetases
US Patent:
2013020, Aug 8, 2013
Filed:
Apr 29, 2011
Appl. No.:
13/695229
Inventors:
Leslie Ann Greene - San Diego CA, US
Kyle P. Chiang - Cardiff CA, US
Fei Hong - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry Dean Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
Wing-Sze Lo - Chai Wan, HK
John D. Mendlein - Encinitas CA, US
Kyle P. Chiang - Cardiff CA, US
Fei Hong - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry Dean Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
Wing-Sze Lo - Chai Wan, HK
John D. Mendlein - Encinitas CA, US
Assignee:
Pangu BioPharma Limited - Hong Kong
aTyr Pharma, Inc. - San Diego CA
aTyr Pharma, Inc. - San Diego CA
International Classification:
C12N 9/00, C07K 16/40, C12N 5/071, C12N 9/96, G01N 33/68
US Classification:
424 945, 435183, 435188, 530350, 435325, 435 74, 435375, 514 212, 514 182, 514 69, 514 193, 5303879
Abstract:
Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.
Innovative Discovery Of Therapeutic, Diagnostic, And Antibody Compositions Related To Protein Fragments Of Tyrosyl-Trna Synthetases
US Patent:
2013023, Sep 5, 2013
Filed:
Aug 25, 2011
Appl. No.:
13/818929
Inventors:
Leslie Ann Greene - San Diego CA, US
Kyle P. Chiang - Cardiff CA, US
Fei Hong - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Wing-Sze Lo - Chai Wan, HK
Jeffry D. Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
John D. Mendlein - Encinitas CA, US
Kyle P. Chiang - Cardiff CA, US
Fei Hong - San Diego CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Wing-Sze Lo - Chai Wan, HK
Jeffry D. Watkins - Encinitas CA, US
Cheryl L. Quinn - Minneapolis MN, US
John D. Mendlein - Encinitas CA, US
Assignee:
PANGU BIOPHARMA LIMITED
ATYR PHARMA, INC. - San Diego CA
ATYR PHARMA, INC. - San Diego CA
International Classification:
C12N 9/00
US Classification:
424 945, 435 74, 435183, 435188, 435375, 530350
Abstract:
Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.
Aminoacyl Trna Synthetases For Modulating Hematopoiesis
US Patent:
2011015, Jun 23, 2011
Filed:
Dec 10, 2010
Appl. No.:
12/965655
Inventors:
Jeffry Dean Watkins - Encinitas CA, US
Alain P. Vasserot - Carlsbad CA, US
Rajesh Belani - San Diego CA, US
Leslie Ann Greene - San Diego CA, US
Ryan Andrew Adams - San Diego CA, US
Alain P. Vasserot - Carlsbad CA, US
Rajesh Belani - San Diego CA, US
Leslie Ann Greene - San Diego CA, US
Ryan Andrew Adams - San Diego CA, US
Assignee:
ATYR PHARMA, INC. - San Diego CA
International Classification:
A61K 39/395, A61K 38/53, C12N 5/078, A61K 35/12, C07H 21/00, C12N 15/63, C12N 5/10, C12N 9/00, C07K 16/18, C07K 14/00, A61P 7/00
US Classification:
4241391, 424 945, 435377, 424 937, 536 232, 4353201, 435325, 435183, 5303879, 530300
Abstract:
Hematopoietic-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof, as well as compositions comprising related agents such as antibodies and other binding agents. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of hematopoiesis.
Anti-Egfr Antibodies
US Patent:
2010016, Jul 1, 2010
Filed:
Mar 12, 2010
Appl. No.:
12/723065
Inventors:
Catherine Brautigam BEIDLER - Poway CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry Dean Watkins - Encinitas CA, US
Alain Philippe Vasserot - Carlsbad CA, US
Jeffry Dean Watkins - Encinitas CA, US
Assignee:
APPLIED MOLECULAR EVOLUTION - San Diego CA
International Classification:
A61K 39/395, C07K 16/00, C07H 21/04, A61P 35/00, C12N 15/63, C12N 5/10
US Classification:
4241331, 53038822, 5303873, 536 2353, 4353201, 435325
Abstract:
The present invention encompasses EGFR specific monoclonal antibodies, or antigen-binding portions thereof. These antibodies, or antigen-binding portions thereof, have high affinity for EGFR, inhibit the activation of EGFR, and are useful for the treatment of EGFR mediated cancers.